Finally, some sanity. Perhaps maybe medicine can return to helping patients rather than primarily being income streams and restricting technology.
A federal judge on Monday struck down patents on two genes linked to breast and ovarian cancer. The decision, if upheld, could throw into doubt the patents covering thousands of human genes and reshape the law of intellectual property.
It is simple insanity and greed to say a private company can patent a human gene. It’s a symptom of our how deranged our legal and ethical systems have become that such a thing was even considered much less permitted.
John Ball, executive vice president of the American Society for Clinical Pathology, one of the plaintiffs in the case, called the decision “a big deal.”
“It’s good for patients and patient care, it’s good for science and scientists,” he said. “It really opens up things.”